Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism

被引:11
|
作者
Giovanella, L. [1 ,2 ,3 ,4 ]
Ceriani, L. [1 ,2 ]
Ghelfo, A. [5 ,6 ]
机构
[1] Oncol Inst So Switzerland, PET CT Ctr, Dept Nucl Med, CH-6500 Bellinzona, Switzerland
[2] Oncol Inst So Switzerland, Thyroid Unit, CH-6500 Bellinzona, Switzerland
[3] Ente Osped Cantonale, Dept Clin Chem, Bellinzona, Switzerland
[4] Ente Osped Cantonale, Lab Med, Bellinzona, Switzerland
[5] Univ Hosp Osped Circolo, Lab Endocrinol & Tumour Markers, Varese, Italy
[6] Fdn Macchi, Varese, Italy
关键词
thyrotropin receptor antibodies; hyperthyroidism; quantitative thyroid scintigraphy; radio-receptor assay; 99mTc-pertechnetate;
D O I
10.1055/s-2008-1065320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease (GD) is characterized by circulating TSH receptor antibodies (TRAb), and so-called hyperthyroid autoimmune thyroiditis (H-AIT) generally shows negative TRAb results with first-generation assays. However, a positive titer was observed in up to 13 % of patients with euthyroid or hypothyroid autoimmune thyroiditis (AIT) by second-generation TRAb assays, and a larger increase is expected in hyperfunctioning forms. A thyroid 99mTc-pertechnetate uptake (TcTUs) cutoff of 2% previously was shown to accurately discriminate between GD and H-AIT. Here we evaluated the relationship between second-generation TRAb assays and TcTUs in 139 patients with untreated autoimmune hyperthyroidism. An increase in TRAb levels was found in 114 of 139 patients (82%). All patients with TcTUs >2% and 66% of those with lower values had positive TRAb measurements. When the cutoff was increased to 5.9U/l, positive TRAb occurred in 92.6% of those having higher TcTUs and in 1.4 % of those with lower TcTUs. TRAb levels significantly increased in patients with TcTUs higher than 2% as compared with those having lower values, while no differences occurred in patients with TcTUs ranging from 0 to 1 %, from 1.1 to 1.5 %, or from 1.6 to 2 %. A significant relationship between TRAb and TcTUs (as well as M, fT4, and thyroid volume) was found. TcTUs, fT4, fT3, and thyroid volume significantly increased in patients with positive TRAb (cutoff 1.5U/l) compared with those testing negative. Our data indicate that a large proportion of patients with hyperthyroidism and hypoechoic thyroid, including those previously diagnosed as having H-AIT, actually have circulating TRAb. TRAb levels predicate the degree of iodine uptake (as measured by TcTUs) and thyroid hyperfunction. The role of baseline TRAb measurement by second-generation assays to predict patients' outcome needs to be further evaluated and compared with TcTUs in prospective studies.
引用
收藏
页码:484 / 486
页数:3
相关论文
共 50 条
  • [1] Anti-thyroid-stimulating hormone receptor antibodies determined by second-generation assay
    Mankai, Amani
    Toumi, Dorsaf
    Chadli-Chaieb, Molka
    Ghedira-Besbes, Leila
    Saad, Fathia
    Ouertani, Mohamed
    Sfar, Habib
    Jeddi, Moncef
    Chaieb, Larbi
    Ghedira, Ibtissem
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (01) : 26 - 29
  • [2] Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism
    Abeillon-du Payrat, Juliette
    Chikh, Karim
    Bossard, Nadine
    Bretones, Patricia
    Gaucherand, Pascal
    Claris, Olivier
    Charrie, Anne
    Raverot, Veronique
    Orgiazzi, Jacques
    Borson-Chazot, Francoise
    Bournaud, Claire
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (04) : 451 - 460
  • [3] Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease
    Zophel, K
    Wunderlich, G
    Koch, R
    Franke, WG
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2000, 39 (04): : 113 - 120
  • [4] Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease
    Costagliola, S
    Morgenthaler, NG
    Hoermann, R
    Badenhoop, K
    Struck, J
    Freitag, D
    Poertl, S
    Weglöhner, W
    Hollidt, JM
    Quadbeck, B
    Dumont, JE
    Schumm-Draeger, PM
    Bergmann, A
    Mann, K
    Vassart, G
    Usadel, KH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01): : 90 - 97
  • [5] Predictive VALUE of Maternal Second Generation Tbii ASSAY for Neonatal Autoimmune Hyperthyroidism
    Abeillon-du Payrat, Juliette
    Chikh, Karim
    Bretones, Patricia
    Gaucherand, Pascal
    Claris, Olivier
    Charrie, Anne
    Raverot, Veronique
    Orgiazzi, Jacques
    Borson-Chazot, Francoise
    Bournaud, Claire
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [6] Evaluation of a second-generation thyrotropin automated immunoassay
    BoonFalleur, L
    DeNayer, P
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1996, 34 (01): : 73 - 76
  • [7] THYROTROPIN-RECEPTOR COMPLEX BINDING-ANTIBODIES IN AUTOIMMUNE THYROID-DISEASES
    KONISHI, J
    IIDA, Y
    MISAKI, T
    ENDO, K
    KUMA, K
    TORIZUKA, K
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1639 - 1639
  • [8] CONNATAL HYPERTHYROIDISM CAUSED BY PLACENTAL TRANSMISSION OF THYROTROPIN RECEPTOR ANTIBODIES
    EYB, H
    SPERGER, H
    BORKENSTEIN, M
    MULLER, W
    PASSATH, A
    KLINISCHE PADIATRIE, 1988, 200 (01): : 74 - 77
  • [9] Predictive value of thyrotropin receptor antibodies using the second generation TRAb human assay after radioiodine treatment in Graves' disease
    Zöphel, K
    Wunderlich, G
    Kopprasch, C
    Koch, R
    Franke, WG
    Kotzerke, J
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2003, 42 (02): : 63 - 70
  • [10] Attenuation of Induced Hyperthyroidism in Mice by Pretreatment with Thyrotropin Receptor Protein: Deviation of Thyroid-Stimulating to Nonfunctional Antibodies
    Misharin, Alexander V.
    Nagayama, Yuji
    Aliesky, Holly A.
    Mizutori, Yumiko
    Rapoport, Basil
    McLachlan, Sandra M.
    ENDOCRINOLOGY, 2009, 150 (08) : 3944 - 3952